Spruce Biosciences Stock Target Price and Analyst Consensus
| SPRB Stock | USD 90.70 3.59 4.12% |
The current analyst and expert consensus on Spruce Biosciences is Hold with 5 hold recommendations. The current projected Spruce Biosciences target price consensus is 230.50 with 5 analyst opinions. One of the most common ways Spruce Biosciences Common analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Spruce Biosciences vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Spruce Biosciences. We strongly encourage you to use your own analysis of Spruce Biosciences Common to validate this buy or sell advice. Spruce Biosciences recommendation module provides expert sentiment on the projected Spruce Biosciences Common target price to derive its highest and lowest estimates based on target price standard deviation of 8.5756.
Lowest Forecast 209.76 | Highest Forecast 255.86 | Target Price 230.5 |
It's important to approach Spruce Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Spruce Biosciences Target Price Consensus
Spruce target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Spruce Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Hold |
Most Spruce analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Spruce stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Spruce Biosciences Common, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSpruce Biosciences Target Price Projection
Spruce Biosciences' current and average target prices are 90.70 and 230.50, respectively. The current price of Spruce Biosciences is the price at which Spruce Biosciences Common is currently trading. On the other hand, Spruce Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Spruce Biosciences Market Quote on 3rd of January 2026
Target Price
Analyst Consensus On Spruce Biosciences Target Price
Spruce Biosciences Analyst Ratings
Spruce Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Spruce Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Spruce Biosciences' financials, market performance, and future outlook by experienced professionals. Spruce Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Spruce Biosciences price targets
Spruce Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Spruce Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Spruce Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Spruce Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Spruce Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Spruce Biosciences is a key component of Spruce Biosciences valuation and have some predictive power on the future returns of a Spruce Biosciences.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Robots And Drones Invested few shares | |
 | Compulsion Invested over 60 shares | |
 | Baby Boomer Prospects Invested one share | |
 | Impulse Invested over 40 shares | |
 | IT Invested over 100 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Giant Impact Invested one share | |
 | Power Assets Invested over 200 shares |
Check out Macroaxis Advice on Spruce Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Please note, the presentation of Spruce Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Spruce Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Spruce Biosciences' management manipulating its earnings.